NCT06760026

Brief Summary

Morbidity associated with post-cesarean wound closure, including cosmetically unfavorable scarring, is a significant concern in obstetrics, impacting patient satisfaction and recovery. Recent advances have introduced the use of tissue adhesives, such as 2-octylcyanoacrylate, which promise to improve cosmetic outcomes and reduce postoperative complications. This study will evaluate different tissue adhesive application schedules, keeping the total dose constant, to determine whether the method of application influences cosmetic results and the incidence of postoperative complications

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 30, 2024

Completed
2 days until next milestone

Study Start

First participant enrolled

January 1, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 6, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

February 17, 2026

Status Verified

January 1, 2025

Enrollment Period

7 months

First QC Date

December 30, 2024

Last Update Submit

February 13, 2026

Conditions

Keywords

Cesarean Wound RepairCesarean section scarcosmetic appearance of cesarean scartissue adhesives

Outcome Measures

Primary Outcomes (1)

  • Changes in the OSAS Scale score

    The OSAS score is based on the assessment of several aspects of a scar, and each of these aspects is scored individually. Each variable uses a 10-point scoring system, where 1 represents normal foot. The scores of the individual variables can be added together to obtain a total score ranging from 5 to 50, where 5 represents normal skin. Items typically assessed include: * Vascularity: Refers to the presence of visible blood vessels or red coloration in the scar. * Pigmentation: Assesses whether the scar has a different color than the surrounding skin. * Thickness: Refers to the height or prominence of the scar above the level of the surrounding skin. * Relief: Assesses the texture of the scar compared to the surrounding skin. * Flexibility: Measures how stiff or flexible the scar is compared to the surrounding skin.

    One month from the first intervention until 6 months

Secondary Outcomes (1)

  • PSAS scale score

    One month from the first intervention until 6 months

Study Arms (2)

Intervention

EXPERIMENTAL

use 2-octyl cyanoacrylate tissue adhesive applied continuously over the Pfannenstiel-type cesarean incision

Procedure: 2-octyl cyanoacrylate tissue adhesive applied continuously over the Pfannenstiel-type cesarean incision

Control

ACTIVE COMPARATOR

wound closure with subdermal sutures using 2-0 nylon thread

Procedure: subdermal suture

Interventions

2-octyl cyanoacrylate tissue adhesive applied continuously over the Pfannenstiel-type cesarean incision

Intervention

wound closure with subdermal sutures using 2-0 nylon thread, under the same evaluation scheme

Control

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Submission of a signed and dated informed consent form.
  • Declared willingness to comply with all study procedures and availability for the duration of the study.
  • Pregnant patient at 37 or more weeks gestation, scheduled for elective cesarean section at the Hospital Materno Infantil.
  • Cesarean section performed in the Maternity and Children's Hospital, operating room.
  • Literate patient, able to understand and respond to the study questions, with body mass index less than 30.
  • Possess cell phone or other means of communication to facilitate postoperative follow-up.
  • Residing in the city of Tegucigalpa, Honduras, to ensure accessibility to scheduled follow-up visits.

You may not qualify if:

  • Patients under 18 years of age.
  • Patients with diagnosed psychiatric illnesses that may interfere with their ability to give informed consent or follow the study protocol.
  • Pregnant patients with complications that may affect the healing process or increase the risk of postoperative complications, such as severe preeclampsia.
  • Diabetes.
  • Collagen diseases.
  • Autoimmune diseases (rheumatoid arthritis, Crohn's disease).
  • Vascular diseases (vasculitis).
  • Coagulation disorders (thrombophilia).
  • Pregnant patients with premature rupture of membranes, since this may influence the choice of timing and method of cesarean section.
  • Pregnant patients diagnosed with chorioamnionitis, which represents an increased risk of postoperative infection.
  • Pregnant patients diagnosed with acute abdomen, which may require emergency surgical management that is not compatible with standard cesarean section procedures.
  • Pregnant patients with multiple pregnancies, since this could complicate the cesarean section procedure and affect the results of the study.
  • Presence of major fetal malformations that may require additional interventions at birth.
  • Fetal stillbirth

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Escuela

Tegucigalpa, Francisco Morazán Department, 11101, Honduras

Location

Related Publications (1)

  • Cromi A, Ghezzi F, Gottardi A, Cherubino M, Uccella S, Valdatta L. Cosmetic outcomes of various skin closure methods following cesarean delivery: a randomized trial. Am J Obstet Gynecol. 2010 Jul;203(1):36.e1-8. doi: 10.1016/j.ajog.2010.02.001. Epub 2010 Apr 24.

    PMID: 20417924BACKGROUND

Study Officials

  • Ricardo A. Gutierrez Ramirez, MD, MSc

    Universidad Nacional Autonoma de Honduras

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Both the patient and the principal investigator will know the intervention, the data analyst researcher does not know the group to which the patients have been assigned.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Single-blind, parallel-group, randomized clinical trial of superiority
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Titular professor

Study Record Dates

First Submitted

December 30, 2024

First Posted

January 6, 2025

Study Start

January 1, 2025

Primary Completion

July 31, 2025

Study Completion

December 30, 2025

Last Updated

February 17, 2026

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

It is not necessary, none of the 18 HIPAA identifiers will be placed

Locations